GGrantIndex
Sort

46,585 grants matching heart failure

Macrophage heterogeneity in atrial remodeling

$587,444
Maarten Hulsmans · Massachusetts General Hospital · R01 · FY2021 · HL

Plasma sphingolipids and risk of cardiovascular disease

$587,431
Rozenn Lemaitre · University Of Washington · R01 · FY2017 · HL

Renal ion channels in the control of blood pressure

$587,314
Alexander Staruschenko · Medical College Of Wisconsin · R35 · FY2021 · HL

Renal ion channels in the control of blood pressure

$587,314
Alexander Staruschenko · Medical College Of Wisconsin · R35 · FY2019 · HL

Strength Training Regimen fOr Normal weiGht Diabetics (STRONG-D)

$587,314
Latha P Palaniappan · Palo Alto Medical Foundation Res Inst · R01 · FY2014 · DK

Renal ion channels in the control of blood pressure

$587,314
Alexander Staruschenko · Medical College Of Wisconsin · R35 · FY2020 · HL

Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits

$587,289
Gideon Koren · Rhode Island Hospital · R01 · FY2011 · HL

The New York CKD Biomarker Discovery Program

$587,281
Erwin P. Bottinger · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · DK

Mediator kinase regulation of cardiac transcription

$587,249
Chad E Grueter · University Of Iowa · R01 · FY2024 · HL

Mediator kinase regulation of cardiac transcription

$587,249
Chad E Grueter · University Of Iowa · R01 · FY2025 · HL

Redefining Human Myocardial Biology

$587,202
Piero Anversa · Brigham And Women'S Hospital · R01 · FY2011 · HL

Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure

$587,161
Shyam Sunder Bansal · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · HL

Worcester Heart Attack Study

$587,148
Robert Joel Goldberg · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · HL

Cardiothoracic Surgical Trials Network

$587,126
Alan Marc Gillinov · Cleveland Clinic Lerner Com-Cwru · UM1 · FY2022 · HL

Responses of Myocardial Ischemia to Sertraline Treatment

$587,118
Wei Jiang · Duke University · R01 · FY2010 · HL

Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy

$587,071
Joshua M Hare · University Of Miami School Of Medicine · UM1 · FY2018 · HL

Regulation of lymphatic muscle cell function by store operated calcium entry signaling

$587,042
Scott D. Zawieja · University Of Missouri-Columbia · R01 · FY2024 · HL

Atrial arrhythmias and Ca2+ waves in HF: simulation and experimental studies

$586,999
John Andrew Wasserstrom · Northwestern University At Chicago · R01 · FY2015 · HL

A Hypertension Emergency department intervention Aimed at Decreasing Disparities

$586,893
Heather Marie Prendergast · University Of Illinois At Chicago · R56 · FY2015 · HL

Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk

$586,845
Susan Heckbert · University Of Washington · R01 · FY2020 · HL

Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk

$586,845
Susan Heckbert · University Of Washington · R01 · FY2021 · HL

The Cause of Systemic Inflammatory Response during Cardiopulmonary Bypass and Prevention by Nitric Oxide

$586,657
Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

Cardiothoracic Surgical Trials Network

$586,654
Alan Marc Gillinov · Cleveland Clinic Lerner Com-Cwru · UM1 · FY2023 · HL

Understanding the role of bilevel positive airway pressure (BPAP) in pediatric acute asthma exacerbations: A prospective, randomized, double blind, controlled trial.

$586,651
Patrick Thomas Wilson · University Of Colorado Denver · R33 · FY2023 · HL

Right Ventricular-Pulmonary Vascular Interactions in Pulmonary Hypertension

$586,650
Naomi C Chesler · University Of Wisconsin-Madison · R01 · FY2014 · HL